Combined with the proteomics and bioinformatics results, as well as the immunohistochemistry staining in clinical specimens, we can conclude that FUBP1 is a special protein that confers lobaplatin resistance in osteosarcoma cells. The gene discussed is FUBP1; the disease is osteosarcoma.